EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Multi-omics analysis of gut-brain axis reveals novel microbial and neurotransmitter signatures in patients with arteriosclerotic cerebral small vessel disease

Jiayuan Huang, Sanxin Liu, Peijie Li, Lei Wei, Gan Lin, Jiahao Lin, Yuting Luo, Yixin Liu, Yudan Mao, Hengfang Ruan, Bing Qin, Ping Fan und 7 weitere

Pharmacological Research · 2024

DOI: 10.1016/j.phrs.2024.107385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2024. Verfasst von Jiayuan Huang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, Guang…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Cerebral Small Vessel Diseases, Brain-Gut Axis, Neurotransmitter Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arteriosclerotic cerebral small vessel disease (aCSVD) is a major cause of stroke and dementia. Although its underlying pathogenesis remains poorly understood, both inflammaging and gut microbiota dysbiosis have been hypothesized to play significant roles. This study investigated the role of gut microbiota in the pathogenesis of aCSVD through a comparative analysis of the gut microbiome and metabolome between CSVD patients and healthy controls. The results showed that patients with aCSVD exhibited a marked reduction in potentially beneficial bacterial species, such as Faecalibacterium prausnitzli and Roseburia intestinalis, alongside an increase in taxa from Bacteroides and Proteobacteria. Integrated metagenomic and metabolomic analyses revealed that alterations in microbial metabolic pathways, including LPS biosynthesis and phenylalanine-tyrosine metabolism, were associated with the status of aCSVD. Our findings indicated that microbial LPS biosynthesis and phenylalanine-tyrosine metabolism potentially influenced the symptoms and progression of aCSVD via pro-inflammatory effect and modulation of systemic neurotransmitters, respectively. These results imply that gut microbiota characteristics may serve as indicators for early detection of aCSVD and as potential gut-directed therapeutic intervention target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCerebral Small Vessel DiseasesBrain-Gut AxisNeurotransmitter AgentsDysbiosisHumansMaleFemaleAgedMiddle AgedMetabolomicsBacteriaMetabolomeMultiomics

Stichwörter der Autor:innen

ArteriosclerosisCerebral small vessel diseaseLive biotherapeutic productsMicrobiomeNeurotransmitter

Substanzen

Neurotransmitter Agents

Autor:innen und Institutionen

  • Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, Guangdong 518107, China.
  • Department of Neurology, Center for the Study of Mental and Neurological Disorders, the Third Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, Guangdong 510630, China.
  • Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, Guangdong 518107, China. Electronic address: mouxy5@ms.sysu.edu.cn.
  • Department of Neurology, Center for the Study of Mental and Neurological Disorders, the Third Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, Guangdong 510630, China. Electronic address…
  • Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, Guangdong 518107, China. Electronic address: zhaowj29@ms.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, J., Liu, S., Li, P., Wei, L., Lin, G., Lin, J., Luo, Y., Liu, Y., Mao, Y., Ruan, H., Qin, B., Fan, P., Lu, T., Cai, W., Yi, H., Mou, X., Lu, Z., Zhao, W., & Wu, A. (2024). Multi-omics analysis of gut-brain axis reveals novel microbial and neurotransmitter signatures in patients with arteriosclerotic cerebral small vessel disease. Pharmacological Research. https://doi.org/10.1016/j.phrs.2024.107385

Vancouver

Huang J, Liu S, Li P, Wei L, Lin G, Lin J, et al. Multi-omics analysis of gut-brain axis reveals novel microbial and neurotransmitter signatures in patients with arteriosclerotic cerebral small vessel disease. Pharmacological Research. 2024. doi:10.1016/j.phrs.2024.107385

BibTeX
@article{Huang2024,
  author = {Huang, Jiayuan and Liu, Sanxin and Li, Peijie and Wei, Lei and Lin, Gan and Lin, Jiahao and Luo, Yuting and Liu, Yixin and Mao, Yudan and Ruan, Hengfang and Qin, Bing and Fan, Ping and Lu, Tingting and Cai, Wei and Yi, Haotong and Mou, Xiangyu and Lu, Zhengqi and Zhao, Wenjing and Wu, Aimin},
  title = {Multi-omics analysis of gut-brain axis reveals novel microbial and neurotransmitter signatures in patients with arteriosclerotic cerebral small vessel disease},
  journal = {Pharmacological Research},
  year = {2024},
  doi = {10.1016/j.phrs.2024.107385}
}
Kostenlos starten →